Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 74.98

-1.9%

Nov 20 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2599)	9/22/2009 1:58:08 PM
From: Jibacoa	Read Replies (2) of 3722

TTHI continues its recent UT and is still up 18.01% with volume > 179,800 > 10x its ADV bigcharts.marketwatch.com TTHI has had persistent losses, but has negligent LTD and its ELs for 2009 and 2010 are progressively lower.<g> On July 13 it presented in Vienna the results from a PI which showed that treatment with ELND005, (formerly AZD-103), achieves desired concentrations in brain tissue and cerebrospinal fluid when given orally. It also presented data showing that ELND005 administration is associated with preservation of choline acetyltransferase, reflecting preservation of nerve cells that are critical to memory function in the brain. ELND005 is currently in PII for the treatment of mild to moderate Alzheimer’s disease. The trial is been conducted in its association with ELN Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next